Literature DB >> 15675041

Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine.

Ju-Hong Jeon1, Hye-Jin Lee, Gi-Yong Jang, Chai-Wan Kim, Dong-Myung Shim, Sung-Yup Cho, Eui-Ju Yeo, Sang-Chul Park, In-Gyu Kim.   

Abstract

The treatment of cystamine, a transglutaminase(TGase) inhibitor, has beneficial effects in several diseases including CAG-expansion disorders and cataract. We compared the inhibition characteristics of cystamine with those of cysteamine, a reduced form of cystamine expect-ed to be present inside cells. Cystamine is a more potent inhibitor for TGase than cysteamine with different kinetics pattern in a non-reducing condition. By contrast, under reducing conditions, the inhibitory effect of cystamine was comparable with that of cysteamine. How-ever, cystamine inhibited intracellular TGase activity more strongly than cysteamine despite of cytoplasmic reducing environment, suggest-ing that cystamine itself inhibits in situ TGase activity by forming mixed disulfides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15675041     DOI: 10.1038/emm.2004.74

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  7 in total

1.  Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium.

Authors:  Gundula Min-Oo; Kodjo Ayi; Silayuv E Bongfen; Mifong Tam; Irena Radovanovic; Susan Gauthier; Helton Santiago; Antonio Gigliotti Rothfuchs; Ester Roffê; Alan Sher; Alaka Mullick; Anny Fortin; Mary M Stevenson; Kevin C Kain; Philippe Gros
Journal:  Exp Parasitol       Date:  2010-02-26       Impact factor: 2.011

2.  Heterologous leaky production of transglutaminase in Lactococcus lactis significantly enhances the growth performance of the host.

Authors:  Rui-Yan Fu; Jian Chen; Yin Li
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

Review 3.  Diverse biological activities of the vascular non-inflammatory molecules - the Vanin pantetheinases.

Authors:  Belinda J Kaskow; J Michael Proffitt; J Michael Proffit; John Blangero; Eric K Moses; Lawrence J Abraham
Journal:  Biochem Biophys Res Commun       Date:  2011-12-01       Impact factor: 3.575

4.  Metabolic interactions between cysteamine and epigallocatechin gallate.

Authors:  Valentina Izzo; Federico Pietrocola; Valentina Sica; Sylvère Durand; Sylvie Lachkar; David Enot; José Manuel Bravo-San Pedro; Alexis Chery; Speranza Esposito; Valeria Raia; Luigi Maiuri; Maria Chiara Maiuri; Guido Kroemer
Journal:  Cell Cycle       Date:  2017-01-06       Impact factor: 4.534

Review 5.  Regulation of coenzyme A levels by degradation: the 'Ins and Outs'.

Authors:  Philippe Naquet; Evan W Kerr; Schuyler D Vickers; Roberta Leonardi
Journal:  Prog Lipid Res       Date:  2020-03-29       Impact factor: 16.195

Review 6.  Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo.

Authors:  Thomas M Jeitner; John T Pinto; Arthur J L Cooper
Journal:  Biosci Rep       Date:  2018-09-05       Impact factor: 3.840

7.  Synthesis, Crystal Structure, Spectroscopic Properties, and Interaction with Ct-DNA of Zn(II) with 2-Aminoethanethiol Hydrochloride Ligand.

Authors:  Xu-Gang Shu; Chun-Li Wu; Cui-Jin Li; Min Zhang; Ke Wan; Xin Wu
Journal:  Bioinorg Chem Appl       Date:  2016-02-10       Impact factor: 7.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.